Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Motor Activity 1Lymphoma, Follicular 1Colitis, Ulcerative 1

Interventions

Exercise 22Resistance Training 2Methods 2Diet 2secukinumab 1peficitinib 1blueberry extract 1Wearable Electronic Devices 1Walking 1Tablets 1Surveys and Questionnaires 1Roflumilast 1Psychosocial Intervention 1Psychology, Positive 1Nadolol 1Mindfulness 1Masks 1Isoproterenol 1Hematologic Tests 1Hand Strength 1Exercise Therapy 1Carvedilol 1Cardiac Output 1Body Composition 1Bisoprolol 1Andrographis paniculata extract 1Accelerometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Motor Activity × peficitinib × Lymphoid × Clear all
NCT01959282 2019-01-04

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Janssen Research & Development, LLC

Phase 2 Completed
219 enrolled
Lymphoid

Colitis, Ulcerative, Lymphoma, Follicular, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡